# Patent

## Title
Method for reducing expression variability of transgenes in plant cells

## Abstract

This application is a 371 of PCT/GB/00882 filed Apr. 10, 1996.

## Background
The present invention relates to a promoter sequence capable of giving a high level of expression within plant cells. In particular, it relates to a promoter derived from a gene encoding S-adenosyl-L-homocysteine hydrolase (SHH).

Promoters control the spatial and temporal expression of genes by modulating their level of transcription. Early approaches to genetically engineered crop plants utilised strong constitutive promoters to drive the expression of foreign genes. As strategies in plant biotechnology have become more sophisticated, specific promoters have been used to target transgene expression to a particular tissue or to a particular developmental stage. The promoter of the present invention is especially versatile as it can be used either to give constitutive expression of a gene or to target increased levels of gene expression at sites of wounding or pathogen invasion.

SHH was first described, in rat liver extracts, as the activity responsible for the reversible hydrolysis of S-adenosyl-L-homocysteine (SAH) to adenosine and homocysteine by the cleavage of a thioether bond in SAH [de la Haba, G. and Cantoni, G. L. (1959). J. Biol. Chem. 234, 603-608].

SAH is formed as a direct product of transmethylation reactions involving S-adenosyl-L-methionine (SAM) [Cantoni, G. L. and Scarano, E. (1954). J. Am. Chem. Soc. 76, 4744] and is known to be a potent inhibitor of most SAM mediated methyltransfer reactions. Therefore SAH is converted to homocysteine and adenosine by SHH as shown schematically below: S-adenosyl-L-methionine (SAM) .uparw..dwnarw. Methyltransferase Methylated Product + S-adenosyl-L-homocysteine (SAH) .uparw..dwnarw. SHH Adenosine + L-homocysteine .uparw..dwnarw. N5-methyltetrahydrofolate Methionine ______________________________________

This pathway for the metabolism of SAH is the only pathway in most species. SHH has been found in all cells tested with the exception of Escherichia coli and other related bacteria [Shimzu, S. et al. (1984). Eur. J. Biochem. 141, 385-392].

The unique metabolic role of SHH in the removal of SAH and the structural complexity of the enzyme suggest that SHH may have a role in the regulation of the biological utilisation of SAM. SAM serves as a major methyl group donor for numerous highly specific methyltransferase reactions with a large variety of acceptor molecules; for example phenylpropanoid derivatives, cyclic fatty acids, proteins, polysaccharides and nucleic acids [Tabor, C. W. and Tabor, H. (1984). Adv. Enzymol. 56, 251-282]. It should be noted that SAM also has regulatory functions, namely the allosteric stimulation of threonine synthase. In plants, SHH has been studied primarily in relation to the biosynthesis of various phenylpropanoid derivatives.

Enzymes affecting the intracellular levels of SAH are important in the study of plant methylation reactions because it has been demonstrated that many methyltransferases are inhibited by SAH [Deguchi, T. and Barchos, J. (1971). J. Biol. Chem. 246, 3175-3181]. For example, an enzyme catalysing the methylation of caffeic acid was purified from spinach-beet leaves and found to be potently inhibited by SAH [Poulton, J. E. and Butt, V. S. (1976). Arch. of Biochem. Biophys. 172, 135-142]. Other metabolic pathways of the plant which involve transmethylation are the production of lignin and suberin, which are both derived from phenylalanine, through a series of reactions. These reactions include the methylation of caffeic acid into ferulic acid and also the methylation of s-hydroxyferulic acid into sinapic acid. Both these methylation reactions require SAM and hence produce SAH as a byproduct which needs to be removed by SHH to allow further transmethylation.

Once SHH had been isolated, many factors were calculated, such as the enzyme's pH optimum of 8.5, with a 50% activity between pH 6.5-10. Due to the Km value found for the substrate, L-homocysteine, the synthesis of SAH proceeds in vivo at a significant rate only when L-homocysteine is accumulated [Poulton, J. E. and Butt, V. S.(1976). Arch. of Biochem. Biophys. 172, 135-142].

In vivo, the adenosine produced by the hydrolysis of SAH is not deaminated but is converted to ADP by the successive action of adenosine kinase and adenylate kinase, both of which enzymes have been demonstrated in spinach-beet leaves. If L-homocysteine accumulates, it causes inhibition of SHH activity and therefore in vivo, L-homocysteine appears to be methylated by N5-methyltetrahydrofolate to methionine. Indeed, this reaction has been demonstrated in pea seedling extracts and spinach and barley leaves. Unlike all animal SHH enzymes, plant SHH is not inhibited by adenosine but is instead stabilised by low concentrations [Jakubowski, H. and Guranowski, A. (1981). Biochem. 20, 6877-6881].

The kinetic evidence shows that SHH is a sensitive regulator of SAH utilisation, its activity depending not only upon favourable concentrations of metabolites in relation to equilibrium conditions but also upon the levels of SAM, adenosine and L-homocysteine maintained within the system. These in turn will act as feed back inhibitors or activators to determine the rate of methylation reactions which are sensitive to the levels of SAH [Poulton, J. E. and Butt, V. S. (1976). Arch. of Biochem. Biophys. 172, 135-142].

As previously mentioned SHH has been found in all organisms tested except E. coli and some related species where a two step enzymatic process hydrolyses SAH into adenosine and L-homocysteine. So far the following SHH cDNAs have been isolated and published: Commun. 153, 359-364] 53, 169-175] Accession No. M64306] Accession No. M76556] USA. 89, 4713-4717] USA. 89, 6328-6332]

The high level of homology between SHHs of evolutionary divergent species was highlighted further following isolation of SHH from the rat, from Dictostelium discoideum, from the purple non-sulphur photosynthetic bacterium Rhodobacter capsulatus and then from parsley (Petroselinum crispum). The bacterial SHH shows a remarkable degree of amino acid sequence homology, approximately 65% identity and 77% similarity to the previously isolated SHHs from rat, D. discoideum, human and C. elegans. This is one of the highest levels of sequence conservation ever reported between proteins having a similar function in prokaryotes and humans. Similarly, SHH cDNA from parsley is 64% identical to rat cDNA and there is 79% similarity at the amino acid level. The lack of sequence divergence between species may suggest a stringent requirement for SHH to retain its primary structure for function.

Both the R. capsulatus and the parsley amino acid sequences have an additional amino acid motif in comparison to the rat, D. discoideum, human, C. elegans and L. donovani sequences. R. capsulatus has an additional 36 amino acid region whereas parsley has an additional 41 amino acids. These two additional stretches are found in the same position in the predicted protein sequence, approximately one-third of the distance from the amino terminus. (see FIGS. 3A-3C) although they do not show significant homology.

The present inventors have now isolated SHH from various other plant sources. The first of these was Asparagus officinalis and the nucleotide sequence and deduced amino acid sequences for this (SEQ ID NO 1 and SEQ ID NO 2) together with the positions of the restriction sites are shown in FIGS. 1A-1F.

Asparagus SHH also contains the extra stretch of residues earlier found in the other photosynthetic species, parsley and R. capsulatus and not in SHH cDNAs from non-photosynthetic species. This 41 amino acid stretch, from amino acids 150 to 190 is as well conserved between the dicotyledon species parsley and the monocotyledon species asparagus as is the rest of the sequence although it is not similar to the 36 amino acid stretch from R. capsulatus. This is illustrated in FIGS. 2A, 2B, 3A-3C.

Following this, SHH cDNAs were also isolated from other species and one of the species selected was Arabidopsis thaliana. The promoter derived from the SHH gene from A. thaliana has proved to be particularly useful as it directs a high level of expression of a variety of genes, exemplifed by the reporter genes glucuronidase (GUS) and luciferase (LUC). Promoters from the SHH genes of other species may also be isolated using the same techniques and may also be expected to have useful and advantageous effects.

Therefore, in a first aspect of the present invention, there is provided a promoter derived from an SHH gene.

It is preferred that the SHH gene is that derived from A. thaliana.

The promoter has several useful properties and, in particular, because of the uniformity of the SHH gene over different species, it is capable of directing the expression of a wide variety of effect genes in plants, particularly crop plants such as Arabidopsis, tobacco, oil seed rape, potato, tomato, banana, wheat and maize.

The sequence of the Arabidopsis promoter (SEQ ID NO 3) is shown in FIGS. 5A-5C and thus in a second aspect of the invention, there is provided a promoter having the sequence of SEQ ID NO 3 or a sequence of at least 70% homology thereto.

It is preferred that the sequence of the promoter has not less than 80% homology, and, more preferably 90% homology to SEQ ID NO 3.

Since transmethylation reactions are important components of the biosynthetic machinery in most plant cells, the SHH will be expressed in cells throughout the plant. The promoter derived from the SHH will therefore provide a useful control mechanism for expression of any effect gene in a constitutive manner. The effect gene may be an SHH gene but will more usually be an introduced gene. Examples of introduced effect genes which may be linked to the promoter of the present invention include selectable markers such as NptII, the kanamycin resistance gene, the phosphinothricin resistance gene or the phosphinothricin acetyl transferase (PAT) gene and others such as the glucuronidase (GUS) and luciferase (LUC) reporter genes.

The predicted increase in transmethylation and concomitant increase in SHH activity following wounding or pathogen invasion means that the SHH gene will also be useful in providing increased levels of expression of introduced genes at sites of wounding and pathogen invasion. In this respect, the SHH promoter will be particularly useful for targeting expression of disease resistance genes, for example genes encoding antifungal proteins such as those described in our earlier patent applications published as WO92/15691, WO92/21699 and WO93/05 153. Using the SHH promoter, these antifungal proteins can be targeted to wound sites to prevent fungal invasion or to sites of infection to prevent further spread of the pathogen. The combined constitutive and wound/pathogen induced expression will thus provide a powerful mechanism for the prevention of disease using introduced genes.

In order to direct expression, the promoter and its associated effect gene must, of course be incorporated into a vector and therefore, in a further aspect of the invention there is provided a vector comprising the promoter of the present invention linked to an effect gene.

For expression in dicotyledonous plants binary agrobacterium vectors are particularly suitable whereas for monocotyledonous plants direct DNA delivery vectors are preferred.

As already mentioned above, the sequence of the SHH gene is conserved to a remarkable extent between species. The promoter of the present invention can therefore be used to direct expression in almost any plant species, whether monocotyledonous or dicotyledonous. It is of particular use in crop species such as wheat, maize, oil seed rape, potato, tomato, banana and tobacco.

Thus in a further aspect of the invention there is provided a plant cell transformed with a vector as described above. Transformation may be acheived by standard techniques.

The invention also provides a genetically transformed plant and parts thereof, such as cells protoplasts and seeds, having stably incorporated into the genome the construct of the present invention. Any plant may be chosen but the crop species listed above are particularly preferred.

As already mentioned, the expression of SHH at disease or wound sites means that the promoter will be of particular use in combating disease when linked to an appropriate effect gene.

Therefore, in a further aspect, the invention provides a method of increasing the resistance of a plant to infection by a pathogenic organism, the method comprising transforming the plant with a vector comprising a promoter according to the first aspect of the invention operably linked to a gene conferring resistance to the pathogenic organism.

Examples of genes conferring resistance to pathogenic organisms include the genes encoding antifungal proteins described in WO92/15691, WO92/21699 and WO93/05153.

The isolation of the promoter of the present invention was achieved as a result of the study of SHH in various plant species. The strategy employed was firstly to isolate the gene encoding asparagus SHH. This confirmed the remarkable degree of sequence identity in the SHH gene between plant species and was used as a basis for the design of polymerase chain reaction (PCR) primers which were used to isolate SHH genes from various other plant species including Arabidopsis thaliana. Analysis of the A. thaliana SHH gene revealed a 1849 base promoter, the promoter of the present invention, which, further experimentation demonstrated to be a highly versatile promoter capable of directing expression of different genes in a variety of plant species.

The invention will now be further described for the purposes of illustration only with reference to the following examples and to the figures in which:

FIGS. 1A-F shows the nucleotide and deduced amino acid sequence of asparagus SHH (SEQ ID NOS 1 and 2). In FIGS. 1A-1F, the @ symbols define the positions of the start and finish of the original DB6 clone; the sites indicated were used for the sub-cloning of DB6 and the primers used in PCR experiments are underlined.

FIGS. 2A-2B comprise a comparison of full length predicted SHH protein from asparagus (Dbf) (SEQ ID NO 2) with SHH protein from parsley (Pcshh), the NAD.sup.-  binding site has been underlined in all species.

FIGS. 3A-3C comprise a comparison of SHH predicted amino acid sequence from asparagus (Dbf) with SHH proteins from rat, parsley (Pcshh), R. capsulatus (Rcahcy) and C. elegans (Cehcg); the NAD.sup.-  binding site has been underlined in all species and * denotes amino acids conserved in all species.

FIG. 4A shows the amino acid sequence alignment of cloned PCR products (without the primers) from asparagus (ASP, SEQ ID NO 2), Arabidopsis (ARA, SEQ ID NO 4), tobacco (TOB, SEQ ID NO 5), Brachypodium (ERA, SEQ ID NO 6) and wheat (WH and WHU, SEQ ID NOS 7 and 8). The * denote amino acids conerved in every species and denotes conservative amino acid changes.

FIG. 4B is the same as FIG. 4A but with the smaller wheat product removed to highlight sequence conservation between the other five PCR species.

FIGS. 5A-5C shows the SHH promoter sequence from Arabidopsis thaliana (SEQ ID NO 3) including the first 30 amino acids used in translational transgene fusions.

FIGS. 6A-6K comprise a map of the A. thaliana gene showing coding sequence, intron and 3' untranslated region. Important restriction sites are also shown.

FIGS. 7A-7D show the coversion of plasmid pSK AoPR1 FULL LUC via pSK AtSHH LUC to pBI101 At SHH Luc and pSK AtSHH-GUS to pBIN 19 AtSHH GUS and pBI101 At SHH Correct to pBI101 At SHH Wrong.

FIG. 8 shows a comparison of SHH driven LUC activity in stem sections and wounded leaf in tobacco.

FIG. 9 shows SHH driven LUC expression in various tissues in tobacco.

FIG. 10 shows LUC line 11 wounding time course in tobacco.

FIG. 11 shows LUC line 11; open flower non dehisced in tobacco.

FIG. 12 shows SHH driven GUS expression during A. thaliana seedling development.

FIG. 13 shows SHH driven GUS expression in various A. thaliana tissues. Hydrolase

This research utilised previously constructed cDNA libraries derived from an mRNA population purified from mechanically separated Asparagus officinalis cells that had been prepared from asparagus seedlings by grinding in a mortar and pestle [Paul, E. et al. (1989), Plant Science, 65, 111-117 and Harikrishna, K., et.al. (1991), Journal of Experimental Botany, 42, 791-797].

Clones were randomly picked from the existing cDNA library made using mRNA extracted from model system cells 1-3 days after mechanical isolation and short stretches of derived sequence data. This data was analysed using Pearson and Lipman searches for homologous known sequences within the EMBL database. A putative asparagus SHH cDNA was identified in this manner and called DB6. This clone was subcloned and the full sequence was derived. The positions of the restriction sites used for this purpose are shown in FIGS. 1A-1F.

The nucleotide sequence itself and the translation of this deduced 1633 bp sequence were compared to the published SHH clones (particularly the parsley SHH), which demonstrated that DB6 was not full length, with 11 amino acids being absent from the amino terminus. Therefore existing libraries were rescreened using the DB6 insert as a probe and a full length version isolated (SEQ ID NO 1). Interestingly this version, named DBF, was isolated from a different library from the original clone. DB6 was picked from a day 1-3 library whereas DBF was isolated from a day 1 library. Sequence data revealed DBF to encode the full SHH amino acid sequence of 485 residues (SEQ ID NO 2), with 25 bp of 5' untranslated nucleotides, 284 bp of 3'-untranslated nucleotides and a polyA+ tail.

Genomic Southern data has shown that the asparagus SHH is probably a member of a small gene family, as was found with the parsley homolog. As with the parsley SHH, the asparagus SHH has been isolated from a model system. However, whereas a fungal elicitor was added to the cultured parsley cells, the asparagus system does not use elicitor treatment and relies on gene induction due to the mechanical isolation of the cells, and therefore it aims to isolate wound induced genes.

FIGS. 2A, 2B and 3A-3C show the asparagus SHH also contains the extra stretch of residues found in the photosynthetic species parsley and R. capsulatus and not in the other cloned SHH cDNAs from non-photosynthetic species. This 41 amino acid stretch, from 150-190 amino acids is as well conserved between the dicotyledon parsley and the monocotyledon asparagus as is the rest of the amino acid sequence, unlike the 36 residue stretch of R. capsulatus. Sequence Conservation

To enable further studies as to the significance of this `extra` region in photosynthetic organisms amino acid sequence of SHH, PCR (Polymerase Chain Reaction) primers were designed to either side of the 41 amino acid stretch common to parsley and asparagus SHH. The primers designed were the following and are shown in context of the SHH cDNA in FIGS. 1A-1F:

PCR-1 (SEQ ID NO 10)

PCR-2 (SEQ ID NO 11)

It was expected that a PCR product of 482 bp would be produced in control experiments with asparagus genomic DNA as the template, unless an intron existed between the primer annealing sites in the genomic gene. The possibility of introns between the primer binding sites was ruled out following a PCR experiment showing that the expected 482 bp product was obtained. Of this 482 bp product, 63 bp consist of primer sequence (31 bp+32 bp). The first 9 bp of each primer, at the 5' end, were designed with an XbaI site to facilitate cloning of PCR products.

These PCR primers were used to try and amplify a segment of the SHH gene from several plant species whose DNA was available within the laboratory. For all species tested, similar sized products were obtained. When these products were hybridised to the asparagus SHH cDNA probe good hybridisation was observed. SHH PCR products were amplified from Arabidopsis, Asparagus (as a control), Tobacco, Brachypodium and Wheat. A single 480 bp PCR product was produced from the Arabidopsis, Asparagus and Brachypodium experiments; whereas wheat and tobacco both produced further products of 350 bp and 700 bp respectively, in addition to the predicted size product. In all cases a product of the predicted size was found. The second tobacco product of 700 bp was later proved to be this size due to multimers of PCR-2 primer sequence on one end, as a result of ligation or PCR error.

The other wheat product was smaller than predicted (350 bp) and when it was cloned and sequenced it was revealed why this was the case. Initial attempts to clone the PCR products into pBluescript (Trade Mark) using the XbaI site within the primers failed except for the control product from asparagus. Therefore a commercial vector available specifically for the cloning of PCR products was used, this vector is called PCRII. The vector utilises the fact that Taq polymerase used in PCR will add single deoxyadenosines to the 3'-end of all duplex molecules, therefore eliminating the need for restriction sites within the primers. All the PCR products from each species mentioned were cloned in this manner and then sequenced. This sequence data revealed why the initial attempts at cloning into pBluescript had failed. During the PCR reaction, for an unknown reason, the whole primer had not always been replicated at its 5'-end, causing the recognition site of XbaI not to be present in the final product. In most cases one primer had the site while the other did not.

All the clones were sequenced and multiple line-ups performed as can be seen in FIG. 4 which compares the deduced amino acid sequences for asparagus (SEQ ID NO 1), A. thaliana (SEQ ID NO 4), tobacco (SEQ ID NO 5), Brachypodium (SEQ ID NO 6) and the two wheat products (SEQ ID NOS 7 and 8). The smaller of the two wheat products proved to be more closely related to the nonphotosynthetic cDNAs isolated, in that it did not contain the extra stretch of 41 amino acids found in parsley and asparagus. The validity of this product needs to be checked as it may have arisen through contamination. Computer analysis has already proven this not to be the same as the Human SHH, previously cloned. However as a 480 bp wheat product was also cloned this could enhance the argument that SHH genes exist as small gene families encoding enzymes with differing biological/physiological roles.

In summary these data shows the SHH gene sequences to be highly conserved across the plant kingdom for the following reasons; firstly, the PCR primers facilitated the successful amplification of the SHH sequence from every tested plant species and secondly, the actual nucleotide and predicted amino acid sequence of this region shows how conserved the SHH gene is between plant species spanning the monocotyledon/dicotyledon classification. (See FIG. 4).

Thus it has been shown that the SHH amino acid sequence is highly conserved between a diverse range of plant species.

Molecular and Biochemical Characterisation

It was predicted that an accumulation of SAH would inhibit the SAM mediated caffeic acid-O-methyltransferase reaction.

If, as suggested, SHH has a central role in allowing the transmethylation reactions of several metabolic pathways to occur unhindered it must be present and active in specific regions of the plant at specific developmental periods. Therefore the well studied lignification process occurring in the stems of maturing tobacco where two well characterised transmethylation reactions occur in the biosynthesis of lignin precursors would confirm the point. Although SHH transcript levels may vary between organs, for example lignifying stems, leaves, roots, pollen etc., it does not necessarily mean that the activity of the enzyme will be altered.

To examine the expression of the SHH gene in a range of tobacco organs, steady state mRNA levels were determined using northern analysis and enzyme assays were used to determine the level of enzyme activity.

Northerns were performed using standard techniques with the tobacco PCR product (FIG. 4) or cDNA as a hybridisation probe. Extraction of SHH enzyme and assay of activity were performed as follows:

All extraction steps were performed at 4.degree. C. with 2 v/w extraction buffer [100 mM Tris pH8, 10 mM Sodium Metabisulphite, 10 mM Ascorbic Acid and 5 mM DTT added on day of use], acid washed sand and 0.1 g of insoluble PVP. supernatant, noting the volume and add 0.56 g of solid ammonium sulphate per ml. Stir for 30 min. resuspension buffer [100 mM Tris pH8 and 5 mM DTT added on day of use] and clarify the solution by pulse centrifugation. been pre-equilibrated with resuspension buffer according to the manufacturer's protocol. The resultant eluate is used in the following assay procedure. 100 .mu.l of 20 mM adenosine) min. plate containing fluorescent indicator (F254, Merck). Develop the plate for a distance of 10 cm in butan-1-ol+acetic acid+water (12:3:5). lamp at 254 nm. Cut out these areas and elute the silica from the plate with 0.5 ml methanol before scintillation counting.

Northern analysis showed the SHH transcript to be detected at very low levels in most tissues tested. SHH enzyme assays demonstrated that transcript levels and enzyme activity levels do correlate strongly. Inducible SHH enzyme activity was found in wounded tissue from asparagus, tobacco and Arabidopsis when compared with SHH enzyme activity in unwounded tissue. The products of the enzyme assay were separated on a TLC plate according to Poulton and Butt (Archives of Biochemistry and Biophysics 172, 135-142, 1976) and both .sup.14 C labelled adenosine and S-adenosyl homocysteine were detected. The rf values of both .sup.14 C labelled compounds compared favourably with those obtained for unlabelled sources that were run on the plates simultaneously and detected by UV fluorescence. In the absence of homocysteine or enzyme preparation, no fluorescent products were observed with the same rf values as unlabelled SAH. These data demonstrate that .sup.14 C labelled SAH was derived from the catalytic conversion of .sup.14 C labelled adenosine and homocysteine by the SAH enzyme present in the plant preparations.

The PCR fragment of the SHH gene from Arabidopsis was used to screen an Arabidopsis genomic library for the corresponding gene using standard techniques. Positive clones arising from the screen were analysed and the SHH gene sequenced from a candidate clone containing the gene and its promoter control regions. The DNA sequence of the promoter is shown in FIGS. 5A-5C and the DNA and deduced amino acid sequence of the coding region in FIGS. 6A-6K.

The Arabidopsis gene sequence described above was used in a series of experiments to modulate SHH gene activity either by down-regulation using antisense or partial sense constructs or by over-expression using the full coding sequence thus reducing the increasing SHH enzyme activity respectively. Effects in specific plant organs or at particular sites of metabolism may be achieved through use of appropriate gene promoters; for example, the lignification process may be modified by using a gene promoter isolated from a gene specific to lignifying tissues such as cinnamoyl:CoA reductase or cinnamyl alcohol dehydrogenase. Alternatively, specific organs may be targeted such as the anthers using the Arabidopsis A9 or APG promoters or pollen using the maize ZM13 promoter. Furthermore gene activity could be modified at sites of pathogen attack or wounding through use of wound promoter e.g. AoPRI from asparagus. Finally, SHH enzyme activities may be modified throughout the plant by using a promoter expressed in most plant tissues e.g. CaMV 35S.

The promoter isolated from the Arabidopsis SHH gene has been tested in transgenic tobacco plants and in A. thaliana to establish its pattern of expression. As shown below this promoter has high level expression in all organs analysed and an additional activity which is induced following wounding. It therefore has utility as a constitutive promoter for expression of selectable markers for in vitro selection of transformants or for high level expression in mature plants. Furthermore, the wound induced activity may be used for directing gene products (e.g. antifungal proteins) to sites of wounding or pathogen invasion. Construction of the SHH promoter--reporter gene were undertaken as follows:

1. Transcriptional fusions between the SHH promoter and the luciferase (LUC) reporter gene.

The following construct is based on pSK AoPR1-LUC as described previously (Warner et al. The Plant Journal 6:31-43,1994). This construct (FIG. 7) was digested with NcoI and XhoI to remove the AoPRI promoter. Using these sites the Arabidopsis SHH promoter was ligated into the plasmid in front of Luc via an NcoI site to create pSK AtSHH-LUC (FIGS. 7A-7D), a cloning intermediate.

The binary vector pBI01 AoPR1-LUC (Warner et al., 1994) was disgested with BamHI and SalI to remove the AoPRI-LUC cassette and the XhoI/BamHI-digested SHH promoter-LUC reporter cassette from pSK AtSHH-LUC (FIGS. 7A-7D) was ligated into the plasmid to create pBI01 AtSHH-LUC (FIG. 7B).

2. Transcriptional fusions between the SHH promoter and the glucuronidase (GUS) reporter gene.

Similar SHH promoter-reporter cassettes were constructed utilising the GUS reporter in place of the LUC reporter. This facilitated direct comparisons between the two reporters under the control of the same Arabidopsis SHH promoter.

Initially a pSK-derived plasmid containing a NOS terminator behind the GUS gene containing an NcoI site at the initiating methionine codon was digested with NcoI/XhoI. The Arabidopsis SHH promoter was similarly digested and ligated into the vector to create pSK AtSHH-GUS (FIG. 7C). The XhoI/BamHI fragment of this plasmid was then cloned into the BamHI/SalI sites of BIN19 (Bevan, M. (1984), Nucleic Acids Research, 12, 8711-8721) to create a binary plasmid pBIN19 AtSHH-GUS (FIG. 7C).

3. Translational fusions between the SHH promoter and the glucuronidase (GUS) reporter gene.

A simple one step cloning process allowed a further GUS fusion to be made using pBI01. From sequence data it was predicted that a fusion to be made using pBI01 would generate an active transitional fusion between the Arabidopsis SHH promoter and GUS with the first 30 amino acids of the GUS fusion encoded by the SHH gene. This construct was made by ligating the 1949 bp XhoI fragment of the SHH promoter into the SalI site of pBI01. The resultant clone was named pBI01.1 in the opposite orientation (i.e. in the anti-sense orientation) creating pBI01 AtSHH Wrong (FIG. 7D). This construct (FIG. 7D) was used as a negative control in expression studies.

GUS activity was determined using standard techniques (Jefferson). LUC assays were performed essentially as in Ow et al. Science, 234, 856-859, 1986 with modifications described by Warner et al., 1994.

FIGS. 8-11 show luciferase activity data expressed as light units/.mu.g total protein for one representative transgenic tobacco line. Identical reporter expression patterns were observed in several other SHH promoter-LUC and SHH promoter-GUS tobacco transgenic lines.

Similar patterns of reporter gene expression were also observed within transgenic A. thaliana, as demonstrated in FIGS. 12 and 13. These A. thaliana transgenics represent T3 homozygous lines containing a single copy T-DNA. Fluorometric assays of GUS activity within leaves of several fo these lines prove that the exprssion due to the SHH promoter occurs at levels similar to or greater than CaMV35s-driven GUS levels in similar transformants. Of seventy-one individual transformed lines harbouring the pBI121 [Jefferson et al (1987) EMBO J., 6, 3901-3907], the highest activity within leaves was found to be 12040 pmol MU/min/mg, with an average between 2000 and 3000 pmol MU/min/mg [Clarke et al, (1992) Plant Mol. Biol. Reporter, 10, 178-189]. Of the five chosen SHH-GUS A. thaliana homozygous T3 lines, the expression within leaves varies from 20984 pmol MU/min/mg to 4420 pmol MU/min/mg with an average of 13725 pmol MU/min/mg, a greater value than the highest expressing line using pBI121.

Histochemically stained transgenic tobacco tissues supported the expression data for GUS activity in all tissues tested.

These results show that the AtSHH promoter drives reporter gene expression in all tissues tested. The point of interest lies in the respective levels of the expression. AtSHH promoter reporter gene expression levels in transgenic plants were far higher than would be predicted from the levels of endogenous SHH transcript. The results in tobacco may be explainable in terms of aberrant expression driven by the Arabidopsis promoter in the tobacco host plant due to incorrect transcription factors recognising the introduced promoter but the increased levels of expression in A. thaliana suggest that this is not the case. Alternatively, the high levels of reporter gene activity could be a result of stabilisation or high levels of translation of the reporter gene transcript affected by the Arabidopsis SHH 5' leader sequence present in all constructs made.

The AtSHH promoter, has been demonstrated to cause increased reporter gene expression in tobacco and in A. thaliana, and this demonstrates its utility as a high level constitutive promoter.

Furthermore, superimposed on the constitutive expression pattern of the AtSHH promoter is a 2.5-fold increase in expression at wound sites which can be clearly seen in FIG. 10.

To establish utility of the Arabidopsis SHH promoter in directing expression of an ATP gene and providing resistance to a fungal pathogen, the 1760 bp promoter fragment from pSKAt SHH-GUS was amplified by PCR using the primers to change the 5' XhoI site to HindIII and the NcoI site at the ATG start codon to XhoI. The resulting fragment was cloned directly into a pMJB1 vector as a partial HindIII-XhoI fragment such that the promoter is placed upstream of the ATP gene. An omega translational enhancer from tobacco mosaic virus, located between the SHH promoter and the ATP gene is included to increase the level of gene expression. In this example, the ATP gene is Dm-AMP1 obtained from seeds of Dahlia merckii. The resulting construct was introduced into oilseed rape using standard Agrobacterium-mediated transformation techniques. Transformed plants wre screened for expression of the Dm-AMP1 gene using western blotting techniques and expressing lines advanced into detached leaf disease assays with the oil seed rape pathogen Phoma lingam (Gretenkort and Ingram (1993), J. Phytopathology, 137, 89-104). Introduction of the Dm-AMP1 gene and expression by the SHH promoter resulted in increased resistance to infection by Phoma lingam. These observations parallel those obtained when expression of the Dm-AMP1 gene is controlled by a well-known constitutive promoter, 35S, from cauliflower mosaic virus, exemplifying the utility of the SHH promoter in this application. #             SEQUENCE LISTING - -  - - (1) GENERAL INFORMATION: - -    (iii) NUMBER OF SEQUENCES: 10 - -  - - (2) INFORMATION FOR SEQ ID NO: 1: - -      (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1767 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - -     (ii) MOLECULE TYPE: DNA (genomic) - -    (iii) HYPOTHETICAL: NO - -     (iv) ANTI-SENSE: NO - -     (vi) ORIGINAL SOURCE: (A) ORGANISM: SHH GENE - #FROM ASPARAGUS - -     (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION:26..1483 (D) OTHER INFORMATION:/cod - #on.sub.-- start= 26 /product=- # "Asparagus SHH" - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #1: - - CTCGTTTCAG ATCCGATCTG AAGAA ATG GCT CTC CTC GTT - #GAG AAG ACT ACC 52 - #          Met Ala Leu Leu Val - # Glu Lys Thr Thr - #            1      - #         5 - - TCT GGC CGC GAG TAC AAG GTC AAG GAC ATG TC - #T CAG GCC GAC TTC GGC 100 Ser Gly Arg Glu Tyr Lys Val Lys Asp Met Se - #r Gln Ala Asp Phe Gly 10                 - # 15                 - # 20                 - # 25 - - CGC CTC GAG ATC GAG CTC GCT GAG GTC GAG AT - #G CCA GGG CTC ATG GCC 148 Arg Leu Glu Ile Glu Leu Ala Glu Val Glu Me - #t Pro Gly Leu Met Ala 30 - #                 35 - #                 40 - - TGC CGT GCC GAG TTC GGC CCC GCC CAG CCA TT - #C AAG GGC GCA AAA ATC 196 Cys Arg Ala Glu Phe Gly Pro Ala Gln Pro Ph - #e Lys Gly Ala Lys Ile 45     - #             50     - #             55 - - ACT GGA TCC CTC CAC ATG ACG ATC CAA ACT GC - #C GTC CTC ATC GAA ACC 244 Thr Gly Ser Leu His Met Thr Ile Gln Thr Al - #a Val Leu Ile Glu Thr 60         - #         65         - #         70 - - CTA ACC GCC CTC GGG CCC GAG GTT CGC TGG TG - #C TCC TGC AAC ATA TTC 292 Leu Thr Ala Leu Gly Pro Glu Val Arg Trp Cy - #s Ser Cys Asn Ile Phe 75             - #     80             - #     85 - - TCC ACC CAG GAC CAT GCC GCC GCT GCC ATT GC - #C CGT GAC TCC GCC TCC 340 Ser Thr Gln Asp His Ala Ala Ala Ala Ile Al - #a Arg Asp Ser Ala Ser 90                 - # 95                 - #100                 - #105 - - GTC TTC GCC TGG AAG GGT GAG ACC CTC CAG GA - #G TAC TGG TGG TGC ACC 388 Val Phe Ala Trp Lys Gly Glu Thr Leu Gln Gl - #u Tyr Trp Trp Cys Thr 110  - #               115  - #               120 - - GAG CGT GCC CTC GAC TGG GGC CCC GGC GGT GG - #C CCT GAC CTC ATC GTC 436 Glu Arg Ala Leu Asp Trp Gly Pro Gly Gly Gl - #y Pro Asp Leu Ile Val 125      - #           130      - #           135 - - GAT GAC GGC GGC GAC ACC ACT CTC TTG ATC CA - #T GAG GGG GTG AAG GCC 484 Asp Asp Gly Gly Asp Thr Thr Leu Leu Ile Hi - #s Glu Gly Val Lys Ala 140          - #       145          - #       150 - - GAG GAA GAG TAC GAG AAG ACG GGG AAG ATG CC - #C GAT CCG GCG TCT ACC 532 Glu Glu Glu Tyr Glu Lys Thr Gly Lys Met Pr - #o Asp Pro Ala Ser Thr 155              - #   160              - #   165 - - GAC AAT GCT GAG TTC CAG ATC GTG CTC ACA AT - #C ATC AGG GAT GGG CTC 580 Asp Asn Ala Glu Phe Gln Ile Val Leu Thr Il - #e Ile Arg Asp Gly Leu 170                 1 - #75                 1 - #80                 1 - #85 - - AAG GTG GAC CCC ACC AAG TAC AGG AAG ATG AA - #G GAT AGG ATT GTC GGT      628 Lys Val Asp Pro Thr Lys Tyr Arg Lys Met Ly - #s Asp Arg Ile Val Gly 190  - #               195  - #               200 - - GTG TCG GAG GAG ACC ACC ACC GGG GTC AAG AG - #G CTT TAC CAG ATG CAG 676 Val Ser Glu Glu Thr Thr Thr Gly Val Lys Ar - #g Leu Tyr Gln Met Gln 205      - #           210      - #           215 - - GCT AAC AAT TCC CTT CTT TTC CCT GCG ATC AA - #T GTC AAT GAC TCC GTC 724 Ala Asn Asn Ser Leu Leu Phe Pro Ala Ile As - #n Val Asn Asp Ser Val 220          - #       225          - #       230 - - ACC AAG AGC AAG TTT GAC AAT CTG TAT GGA TG - #C CGG CAC TCT CTT CCC 772 Thr Lys Ser Lys Phe Asp Asn Leu Tyr Gly Cy - #s Arg His Ser Leu Pro 235              - #   240              - #   245 - - GAT GGT CTG ATG AGG GCC ACT GAT GTT ATG AT - #T GCT GGC AAG GTT GCA 820 Asp Gly Leu Met Arg Ala Thr Asp Val Met Il - #e Ala Gly Lys Val Ala 250                 2 - #55                 2 - #60                 2 - #65 - - GTT GTC TGC GGT TAT GGT GAT GTC GGA GAG GG - #C TGT GCT GCT GCA CTC      868 Val Val Cys Gly Tyr Gly Asp Val Gly Glu Gl - #y Cys Ala Ala Ala Leu 270  - #               275  - #               280 - - AAG CAG GCT GGT GCC CGT GTT ATT GTG ACG GA - #G ATC GAC CCC ATC TGT 916 Lys Gln Ala Gly Ala Arg Val Ile Val Thr Gl - #u Ile Asp Pro Ile Cys 285      - #           290      - #           295 - - GCT CTT CAA GCC CTA ATG GAG GGT CTT CAG GT - #C CTC ACC CTC GAG GAT 964 Ala Leu Gln Ala Leu Met Glu Gly Leu Gln Va - #l Leu Thr Leu Glu Asp 300          - #       305          - #       310 - - GTT GTC TCA GAG GCG GAT ATC TTT GTT ACC AC - #C ACC GGT AAC AAG GAC 1012 Val Val Ser Glu Ala Asp Ile Phe Val Thr Th - #r Thr Gly Asn Lys Asp 315              - #   320              - #   325 - - ATC ATC ATG CTG GAC CAC ATG AGG AAG ATG AA - #G AAC AAT GCC ATT GTC 1060 Ile Ile Met Leu Asp His Met Arg Lys Met Ly - #s Asn Asn Ala Ile Val 330                 3 - #35                 3 - #40                 3 - #45 - - TGC AAC ATT GGT CAC TTT GAC AAC GAG ATT GA - #C ATG CTA GGT TTG GAG     1108 Cys Asn Ile Gly His Phe Asp Asn Glu Ile As - #p Met Leu Gly Leu Glu 350  - #               355  - #               360 - - ACA TAC CCT GGC ATC AAG AGA ATC ACC ATC AA - #G CCC CAG ACT GAC CGG 1156 Thr Tyr Pro Gly Ile Lys Arg Ile Thr Ile Ly - #s Pro Gln Thr Asp Arg 365      - #           370      - #           375 - - TGG GTC TTC CCT GAA ACC AAC ACT GGT ATA AT - #T GTT CTT GCT GAG GGC 1204 Trp Val Phe Pro Glu Thr Asn Thr Gly Ile Il - #e Val Leu Ala Glu Gly 380          - #       385          - #       390 - - CGA CTC ATG AAC CTT GGG TGT GCC ACT GGT CA - #C CCC AGC TTT GTC ATG 1252 Arg Leu Met Asn Leu Gly Cys Ala Thr Gly Hi - #s Pro Ser Phe Val Met 395              - #   400              - #   405 - - TCC TGC TCC TTC ACC AAC CAG GTG ATT GCT CA - #G CTA GAG TTG TGG AAT 1300 Ser Cys Ser Phe Thr Asn Gln Val Ile Ala Gl - #n Leu Glu Leu Trp Asn 410                 4 - #15                 4 - #20                 4 - #25 - - GAG AAG GCA AGC GGC AAG TAT GAG AAG AAG GT - #T TAC GTG CTC CCC AAG     1348 Glu Lys Ala Ser Gly Lys Tyr Glu Lys Lys Va - #l Tyr Val Leu Pro Lys 430  - #               435  - #               440 - - CAT CTT GAT GAG AAA GTA GCA GCG CTT CAC TT - #G GGC AAG CTC GGA GCC 1396 His Leu Asp Glu Lys Val Ala Ala Leu His Le - #u Gly Lys Leu Gly Ala 445      - #           450      - #           455 - - AAG CTT ACA AAG CTC AGC CCT TCA CAG GCG GA - #C TAC ATC AGC GTC CCC 1444 Lys Leu Thr Lys Leu Ser Pro Ser Gln Ala As - #p Tyr Ile Ser Val Pro 460          - #       465          - #       470 - - ATC GAG GGT CCC TAC AAG CCA CCT CAC TAC AG - #G TAC TAG ACGCTGTTGT 1493 Ile Glu Gly Pro Tyr Lys Pro Pro His Tyr Ar - #g Tyr  * 475              - #   480              - #   485 - - GCCGGGGAGA GATCATCGCA GCAAGAAAGT ATTAAGATTG AAGAAGAGAG TT - #GTTATGGA   1553 - - GGACATGGCT ATATTTACTT TATTTCCTAC CTATTTCTTG CTGTTTCTCT TT - #CCGAACTT   1613 - - TTAGACTGAT CCTCTTCTTC TCTTTGATTT ATTACGATAT GAATTCTGTT TA - #AATTTTGC   1673 - - TTATTCTCTA ATGATGAGCT AGCAGACATA TGTTCTGTGG TAGAATAACG AG - #GTTTTGAA   1733 - - CTTTGTGCAA AAAAAAAAAA AAAAAAAAAA AAAA       - #                  - #      1767 - -  - - (2) INFORMATION FOR SEQ ID NO: 2: - -      (i) SEQUENCE CHARACTERISTICS: (A) LENGTH:  485 ami - #no acids (B) TYPE: amino acid (D) TOPOLOGY: linear - -     (ii) MOLECULE TYPE: protein - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #2: - - Met Ala Leu Leu Val Glu Lys Thr Thr Ser Gl - #y Arg Glu Tyr Lys Val 1               5 - #                 10 - #                 15 - - Lys Asp Met Ser Gln Ala Asp Phe Gly Arg Le - #u Glu Ile Glu Leu Ala 20     - #             25     - #             30 - - Glu Val Glu Met Pro Gly Leu Met Ala Cys Ar - #g Ala Glu Phe Gly Pro 35         - #         40         - #         45 - - Ala Gln Pro Phe Lys Gly Ala Lys Ile Thr Gl - #y Ser Leu His Met Thr 50             - #     55             - #     60 - - Ile Gln Thr Ala Val Leu Ile Glu Thr Leu Th - #r Ala Leu Gly Pro Glu 65                 - # 70                 - # 75                 - # 80 - - Val Arg Trp Cys Ser Cys Asn Ile Phe Ser Th - #r Gln Asp His Ala Ala 85 - #                 90 - #                 95 - - Ala Ala Ile Ala Arg Asp Ser Ala Ser Val Ph - #e Ala Trp Lys Gly Glu 100      - #           105      - #           110 - - Thr Leu Gln Glu Tyr Trp Trp Cys Thr Glu Ar - #g Ala Leu Asp Trp Gly 115          - #       120          - #       125 - - Pro Gly Gly Gly Pro Asp Leu Ile Val Asp As - #p Gly Gly Asp Thr Thr 130              - #   135              - #   140 - - Leu Leu Ile His Glu Gly Val Lys Ala Glu Gl - #u Glu Tyr Glu Lys Thr 145                 1 - #50                 1 - #55                 1 - #60 - - Gly Lys Met Pro Asp Pro Ala Ser Thr Asp As - #n Ala Glu Phe Gln Ile 165  - #               170  - #               175 - - Val Leu Thr Ile Ile Arg Asp Gly Leu Lys Va - #l Asp Pro Thr Lys Tyr 180      - #           185      - #           190 - - Arg Lys Met Lys Asp Arg Ile Val Gly Val Se - #r Glu Glu Thr Thr Thr 195          - #       200          - #       205 - - Gly Val Lys Arg Leu Tyr Gln Met Gln Ala As - #n Asn Ser Leu Leu Phe 210              - #   215              - #   220 - - Pro Ala Ile Asn Val Asn Asp Ser Val Thr Ly - #s Ser Lys Phe Asp Asn 225                 2 - #30                 2 - #35                 2 - #40 - - Leu Tyr Gly Cys Arg His Ser Leu Pro Asp Gl - #y Leu Met Arg Ala Thr 245  - #               250  - #               255 - - Asp Val Met Ile Ala Gly Lys Val Ala Val Va - #l Cys Gly Tyr Gly Asp 260      - #           265      - #           270 - - Val Gly Glu Gly Cys Ala Ala Ala Leu Lys Gl - #n Ala Gly Ala Arg Val 275          - #       280          - #       285 - - Ile Val Thr Glu Ile Asp Pro Ile Cys Ala Le - #u Gln Ala Leu Met Glu 290              - #   295              - #   300 - - Gly Leu Gln Val Leu Thr Leu Glu Asp Val Va - #l Ser Glu Ala Asp Ile 305                 3 - #10                 3 - #15                 3 - #20 - - Phe Val Thr Thr Thr Gly Asn Lys Asp Ile Il - #e Met Leu Asp His Met 325  - #               330  - #               335 - - Arg Lys Met Lys Asn Asn Ala Ile Val Cys As - #n Ile Gly His Phe Asp 340      - #           345      - #           350 - - Asn Glu Ile Asp Met Leu Gly Leu Glu Thr Ty - #r Pro Gly Ile Lys Arg 355          - #       360          - #       365 - - Ile Thr Ile Lys Pro Gln Thr Asp Arg Trp Va - #l Phe Pro Glu Thr Asn 370              - #   375              - #   380 - - Thr Gly Ile Ile Val Leu Ala Glu Gly Arg Le - #u Met Asn Leu Gly Cys 385                 3 - #90                 3 - #95                 4 - #00 - - Ala Thr Gly His Pro Ser Phe Val Met Ser Cy - #s Ser Phe Thr Asn Gln 405  - #               410  - #               415 - - Val Ile Ala Gln Leu Glu Leu Trp Asn Glu Ly - #s Ala Ser Gly Lys Tyr 420      - #           425      - #           430 - - Glu Lys Lys Val Tyr Val Leu Pro Lys His Le - #u Asp Glu Lys Val Ala 435          - #       440          - #       445 - - Ala Leu His Leu Gly Lys Leu Gly Ala Lys Le - #u Thr Lys Leu Ser Pro 450              - #   455              - #   460 - - Ser Gln Ala Asp Tyr Ile Ser Val Pro Ile Gl - #u Gly Pro Tyr Lys Pro 465                 4 - #70                 4 - #75                 4 - #80 - - Pro His Tyr Arg Tyr 485 - -  - - (2) INFORMATION FOR SEQ ID NO: 3: - -      (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1847 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear - -     (ii) MOLECULE TYPE: DNA (genomic) - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #3: - - CTCGAGTGTT GACCTTTTCT GGTCGATTGA ATAGAATCGA ATGTCTTAAT CC - #AGTACCCT     60 - - CCAGCTTTTA TTTCGTGTAA TTTATTTTCC AAACCTACCA CTACCAGTTT CA - #TAACTCTC    120 - - GAATAAATTT ATCAAATAGT CTTTTGAGTG CTCAAAGTCT TGGGATAATA AA - #TGGTCAGT    180 - - GCTATGTATC ACCCGGATGT GAAACATTAT GGGTGGAGAT AGACTATTAT AA - #ATTTATTG    240 - - AAATATACGA TTGTTACTCG TTTAATAGCA AAAGTAGTAC AATGTATATA GT - #TTCTATCG    300 - - AGAACAAGAT CTATTTAAAA TTCGAAAAGT ACATTTAAAA TTCATAAACA TA - #TAAAGATA    360 - - GTAACATGTT AGATCTGCAT AGTACCACCA AAACAAGAAA AAAGAAACGC AC - #ATCGCCAC    420 - - ATAATTGCTA TGATTCTCAC TGTCGGCTGC TTTGAAATAT TCGATTCTTT TG - #GTAAATCA    480 - - CACAACATAA TATAATTACA ATAAATATAT ATATACTAAA GTATAATTAA TA - #TAATTAAT    540 - - ACCACATTGT TTAATTCTGT TTTGATCTTT TAAGATCAGT CAGATCCACC GA - #CGTTCCTA    600 - - CACGCGCAGG TCCAGATCCA AACAGCACAC ACACACACAC AATGCCACTA GT - #GTAAATGC    660 - - TTGGTGGCTA TTGCATTTGC ACCTATTGAT ACTCTTTCTT CAAAAACAAG TT - #ATTGTTTT    720 - - TATTTTCAAC CCAACTTTAA TACGGATTCA TACTGGGATT TAGGTGTTAA AT - #CTGATAAT    780 - - TTAGGTTTGA ATAAGTTGTA TATTTGTTTC TTTGATTAAA AAAAGAACCT AT - #ATATATAC    840 - - AAAAATAAAT AAAAAGTTCT AGATTTCAAT TTTCCGTATA TAGCGGGTTG AA - #TTGTCTAT    900 - - TTTAATATGA AAATTGCGGA TCTTATAAAC AAAATGTTCT GAAATATGTA AA - #AGGATTTA    960 - - GCCAAAGTTA ACCAAAAAAA AAAAAACAAA CAGAAAAGTC ACATTCACAT GT - #CGTGGTAG   1020 - - ATCTAAGGCA TTAATTTAGA AATATGTCGT TACAATAAGC GGAGAACATG GG - #ACGTTTCT   1080 - - CGTGGTCCAA TCAGACGAAC GAGATCTCAT AAATTAAATG ACTTCAGCGA GG - #GAATTCAT   1140 - - GGCAGAATGA TAATGCAACT TAAGTGACTT TAGAGTGAAA ATGATACGAG AA - #CAATGCAT   1200 - - AATCCATATG ACCGTTGAGT GAGTGATACC ATTAGCGCGA TACAAGCGGG AC - #TATAAACT   1260 - - GATCTAGATT GTTTTTCTTG GGAAAAAATG TTACAAATTT TAAATATGTA GT - #TTGAATTG   1320 - - TTAAACCAAG ATTCAACAGA AATATACCGT AAATAAACAA CAGTTGATAA TA - #GTCATCGA   1380 - - AAAGATATCA ACTGATTCTT CACTTGGGCT ACTGTGACGG CCCGTTAGGT TC - #TCAATATA   1440 - - AGTCAATAAC TACGATCTAC GATTCACTGA AACAAATAAA ACACAGCCAC GT - #GTCCACCC   1500 - - TCCCACATCA CCGTCCGATC TAACCCACGA CAAGCTTACA ACACGGGTCA TA - #CCGGCTCG   1560 - - TGCAGCGTGT TCCGTCATCC ACGGGATTAC AACTTCTACC AGATCCACCA AA - #CCCTCAAA   1620 - - ACAATCTGAA CCGTTCATTT CATTTTGACC TCATCTATAT ATTCTCTGTC AC - #TCCCCTTT   1680 - - CTCTTCTCCT CGCACACACT TCTCTCTCTC TCTCTCTCTG CCTCCTTTCG GA - #TTCAAATC   1740 - - TCAGATCTAG CTCAACCATG GCGTTGCTCG TCGAGAAGAC CTCAAGTGGC CG - #TGAATACA   1800 - - AGGTCAAAGA CATGTCTCAA GCCGATTTCG GTCGTCTCGA ACTCGAG   - # 1847 - -  - - (2) INFORMATION FOR SEQ ID NO: 4: - -      (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 140 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - -     (ii) MOLECULE TYPE: protein - -     (vi) ORIGINAL SOURCE: (A) ORGANISM: ARABIDOPSIS - #SHH PROTEIN - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #4: - - His Ala Ala Ala Ala Ile Ala Arg Asp Ser Al - #a Ala Val Phe Ala Trp 1               5   - #                10  - #                15 - - Lys Gly Glu Thr Leu Gln Glu Tyr Trp Trp Cy - #s Thr Glu Arg Ala Leu 20      - #            25      - #            30 - - Asp Trp Gly Pro Gly Gly Gly Pro Asp Leu Il - #e Val Asp Asp Gly Gly 35          - #        40          - #        45 - - Asp Ala Thr Leu Phe Arg Ile His Glu Gly Va - #l Lys Ala Glu Glu Ile 50              - #    55              - #    60 - - Phe Glu Lys Thr Gly Gln Val Pro Asp Pro Th - #r Ser Thr Asp Asn Pro 65                  - #70                  - #75                  - #80 - - Glu Phe Gln Ile Val Leu Ser Ile Ile Lys Gl - #u Gly Leu Gln Val Asp 85  - #                90  - #                95 - - Pro Arg Lys Tyr His Lys Met Lys Glu Arg Le - #u Val Gly Val Ser Glu 100      - #           105      - #           110 - - Glu Thr Thr Thr Gly Val Lys Arg Leu Tyr Gl - #n Met Gln Glu Asn Gly 115          - #       120          - #       125 - - Thr Leu Leu Phe Pro Ala Ile Asn Val Asn As - #p Ser 130              - #   135              - #   140 - -  - - (2) INFORMATION FOR SEQ ID NO: 5: - -      (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 138 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - -     (ii) MOLECULE TYPE: protein - -     (vi) ORIGINAL SOURCE: (A) ORGANISM: TOBACCO S - #HH PROTEIN - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #5: - - His Ala Ala Ala Ala Ile Ala Arg Asp Ser Ar - #g Ala Val Phe Ala Trp 1               5   - #                10  - #                15 - - Lys Gly Glu Thr Leu Gln Glu Tyr Trp Trp Cy - #s Thr Glu Arg Ala Leu 20      - #            25      - #            30 - - Asp Trp Gly Pro Gly Gly Gly Pro Asp Leu Il - #e Val Asp Asp Gly Gly 35          - #        40          - #        45 - - Asp Ala Thr Leu Leu Ile His Glu Gly Val Ly - #s Ala Glu Glu Glu Tyr 50              - #    55              - #    60 - - Ala Lys Ser Gly Lys Leu Pro Asp Pro Ser Se - #r Thr Asp Asn Val Glu 65                  - #70                  - #75                  - #80 - - Phe Gln Leu Val Thr Ile Ile Arg Asp Gly Le - #u Lys Thr Asp Pro Leu 85  - #                90  - #                95 - - Lys Tyr Thr Glu Met Lys Glu Arg Leu Val Gl - #y Val Ser Glu Glu Thr 100      - #           105      - #           110 - - Thr Thr Gly Val Lys Arg Leu Tyr Gln Met Gl - #n Ala Asn Gly Thr Leu 115          - #       120          - #       125 - - Leu Phe Pro Ala Ile Asn Val Asn Asp Ser 130              - #   135 - -  - - (2) INFORMATION FOR SEQ ID NO: 6: - -      (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 139 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - -     (ii) MOLECULE TYPE: protein - -     (vi) ORIGINAL SOURCE: (A) ORGANISM: BRACHYPODIUM - # SHH PROTEIN - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #6: - - His Ala Ala Ala Ala Ile Ala Arg Asp Ser Al - #a Ala Val Phe Ala Trp 1               5   - #                10  - #                15 - - Lys Gly Glu Thr Leu Glu Glu Tyr Trp Trp Cy - #s Thr Glu Arg Cys Leu 20      - #            25      - #            30 - - Asp Trp Gly Val Gly Gly Gly Pro Asp Leu Il - #e Val Asp Asp Gly Gly 35          - #        40          - #        45 - - Asp Pro Thr Leu Leu Ile His Glu Gly Val Ly - #s Ala Glu Glu Glu Phe 50              - #    55              - #    60 - - Glu Lys Ser Gly Lys Ile Pro Asp Pro Glu Se - #r Ala Asp Asn Pro Glu 65                  - #70                  - #75                  - #80 - - Phe Lys Ile Val Leu Thr Ile Ile Arg Asp Gl - #y Leu Lys Thr Asp Ala 85  - #                90  - #                95 - - Arg Lys Tyr Arg Lys Met Lys Glu Arg Leu Va - #l Gly Val Ser Glu Glu 100      - #           105      - #           110 - - Thr Thr Thr Gly Ala Lys Arg Leu Tyr Gln Th - #r Gln Asn Pro Gly Thr 115          - #       120          - #       125 - - Leu Leu Phe Pro Ala Ile Asn Val Asn Asp Se - #r 130              - #   135 - -  - - (2) INFORMATION FOR SEQ ID NO: 7: - -      (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 139 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - -     (ii) MOLECULE TYPE: protein - -     (vi) ORIGINAL SOURCE: (A) ORGANISM: WHEAT SHH - # PROTEIN (1) - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #7: - - Arg Ala Ala Ala Ala Ile Ala Arg Asp Ser Al - #a Ser Val Phe Ala Trp 1               5   - #                10  - #                15 - - Lys Gly Glu Thr Leu Gln Gly Tyr Trp Trp Cy - #s Thr Glu Arg Ala Leu 20      - #            25      - #            30 - - Asp Trp Gly Pro Gly Gly Gly Leu Asp Leu Il - #e Val Asp Asp Gly Gly 35          - #        40          - #        45 - - Asp Thr Thr Leu Leu Ile His Glu Gly Val Ly - #s Ala Glu Glu Glu Tyr 50              - #    55              - #    60 - - Glu Lys Thr Gly Lys Met Pro Asp Pro Thr Se - #r Thr Asp Asn Ala Glu 65                  - #70                  - #75                  - #80 - - Phe Gln Ile Val Leu Thr Ile Ile Arg Asp Gl - #y Leu Lys Val Asp Pro 85  - #                90  - #                95 - - Thr Lys Tyr Arg Lys Met Lys Asp Arg Ile Va - #l Gly Val Ser Glu Glu 100      - #           105      - #           110 - - Thr Thr Thr Gly Val Lys Arg Leu Tyr Gln Me - #t Gln Ala Asn Asn Ser 115          - #       120          - #       125 - - Leu Leu Phe Leu Thr Ile Asn Val Asn Asp Se - #r 130              - #   135 - -  - - (2) INFORMATION FOR SEQ ID NO: 8: - -      (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 99 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - -     (ii) MOLECULE TYPE: protein - -     (vi) ORIGINAL SOURCE: (A) ORGANISM: WHEAT SHH - # PROTEIN (2) - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #8: - - Gln Ala Ala Ala Ala Ile Ala Ala Ala Gly Il - #e Pro Val Phe Ala Trp 1               5   - #                10  - #                15 - - Lys Gly Glu Thr Glu Glu Glu Tyr Glu Trp Cy - #s Ile Glu Gln Thr Ile 20      - #            25      - #            30 - - Leu Lys Asp Gly Lys Pro Trp Asp Ala Asn Me - #t Val Leu Asp Asp Gly 35          - #        40          - #        45 - - Gly Asp Leu Thr Glu Ile Leu His Lys Lys Ty - #r Pro Gln Met Leu Glu 50              - #    55              - #    60 - - Arg Ile His Gly Ile Thr Glu Glu Thr Thr Th - #r Gly Val His Arg Leu 65                  - #70                  - #75                  - #80 - - Leu Asp Met Leu Lys Ala Gly Thr Leu Lys Va - #l Pro Ala Ile Asn Val 85  - #                90  - #                95 - - Asn Asn Ala - -  - - (2) INFORMATION FOR SEQ ID NO: 9: - -      (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 32 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - -     (ii) MOLECULE TYPE: DNA - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #9: - - GCGTCTAGAT GCAACATMTT CTCMACYCAG GA       - #                  - # 32 - -  - - (2) INFORMATION FOR SEQ ID NO: 10: - -      (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 32 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - -     (ii) MOLECULE TYPE: DNA - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO: - #10: - - GCGTCTAGAT TRTCAAACTT GCTCTTGGTR AC       - #                  - # 32 __________________________________________________________________________

## Claims

1. An isolated promoter derived from the S-adenosyl-L-homocysteine hydrolase gene of A. thaliana.

2. An isolated promoter having the nucleotide sequence of that part of SEQ ID NO 3 which is upstream of the methionine codon as shown in FIGS. 5A-5C.

3. A DNA construct comprising a promoter as claimed in claim 1 or claim 2 operably linked to a gene.

4. A DNA construct as claimed in claim 3 wherein said gene is selected from the group consisting of a gene encoding S-adenosyl-L-homocysteine hydrolase, an antifungal protein gene, a selectable marker gene, NptII, a kanamycin resistance gene, a phosphinothricin resistance gene, the phosphinothricin acetyl transferase (PAT) gene, the glucuronidase (GUS) reporter gene, and the luciferase (LUC) reporter gene.

5. A vector comprising a DNA construct as claimed in claim 3 or claim 4.

6. A vector as claimed in claim 5 which is a binary agrobacterium vector or a direct DNA delivery vector.

7. A plant cell transformed with a vector as claimed in claim 5.

8. A genetically transformed plant or part thereof having stably incorporated into the genome the DNA construct as claimed in claim 3 or claim 4.

9. A plant cell or genetically transformed plant according to claim 7 or claim 8, wherein the plant is wheat, maize, oil seed rape, potato, tomato, banana or tobacco.

10. A method of increasing the resistance of a plant to infection by a pathogenic organism, the method comprising transforming the plant with a vector comprising a promoter according to claim 1 or claim 2 operably linked to a gene conferring resistance to the pathogenic organism.

11. A method as claimed in claim 10 wherein the pathogenic organism is a fungus and the gene encodes an antifungal protein.

12. A genetically transformed plant or part thereof according to claim 8 which is a cell, protoplast or seed.